ID: ALA151901

Max Phase: Preclinical

Molecular Formula: C16H23N5S

Molecular Weight: 317.46

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1n[nH]c(SCCN2CCC(Cc3ccccc3)CC2)n1

Standard InChI:  InChI=1S/C16H23N5S/c17-15-18-16(20-19-15)22-11-10-21-8-6-14(7-9-21)12-13-4-2-1-3-5-13/h1-5,14H,6-12H2,(H3,17,18,19,20)

Standard InChI Key:  QBYJJUVRVSZXBY-UHFFFAOYSA-N

Associated Targets(Human)

Glutamate [NMDA] receptor subunit epsilon 1 112 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glutamate [NMDA] receptor subunit epsilon 2 467 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glutamate [NMDA] receptor subunit epsilon 3 47 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 317.46Molecular Weight (Monoisotopic): 317.1674AlogP: 2.43#Rotatable Bonds: 6
Polar Surface Area: 70.83Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.52CX Basic pKa: 8.53CX LogP: 3.23CX LogD: 2.06
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.80Np Likeness Score: -1.52

References

1. Gregory TF, Wright JL, Wise LD, Meltzer LT, Serpa KA, Konkoy CS, Whittemore ER, Woodward RM..  (2000)  Parallel synthesis of a series of subtype-selective NMDA receptor antagonists.,  10  (6): [PMID:10741546] [10.1016/s0960-894x(00)00035-4]

Source